Antacids Market Growth Insights 2020 – by Key Players, Research by Top Trends, Revenue, Share, Business Size Forecast to 2030

The Business Research Company offers “Antacids Global Market Report 2020-30: Covid 19 Impact And Recovery" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global antacids market is expected to decline from $3.6 billion in 2019 to $3.1 billion in 2020 at a compound annual growth rate (CAGR) of -13.9%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 3.9% from 2021 and reach $3.8 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2415

The antacids market consists of sales of antacids which are used to neutralize stomach acid, and treat acid reflux, heartburn and indigestion. It includes drug class such as proton pump inhibitors, H2 antagonist, surgical simulators and acid neutralizers in the form of either tablet, liquid or powder. Examples of antacids include Alka Seltzer, Maalox, Mylanta, Rolaids, Tums and Pepto-Bismol.

Poor lifestyle choices resulting in higher prevalence of acidity is an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep and irregular dietary habits, which result in an increase in acidity level of the stomach and lead to gastroesophageal reflux disease.

Antacids Market Segmentation:
Drug Class:
1.Proton Pump Inhibitors
2.H2 Antagonist
3.Acid Neutralizers
4.Pro-Motility Agents

Distribution Channel:
1.Hospital Pharmacies
2.Retail Pharmacies

By Formulation Type:
1.Tablet
2.Liquid
3.Powder

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Size And Growth
4. Antacids Market Segmentation
5. Antacids Market Regional And Country Analysis
……
26. Key Mergers And Acquisitions In The Antacids Market
27. Antacids Market Trends And Strategies
28. Product Pipeline Analysis
29. Antacids Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the Antacids Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2415&type=smp

Some of the key players involved in the Antacids Market are GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Dr. Reddy`s Laboratories Ltd, AstraZeneca PLC, Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited, Abbott Laboratories , WellSpring Pharm, Private Lable, GSK , Johnson & Johnson, Novartis Consurmer Health, CONBA, Xiuzheng Pharma.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.